In the context of APLAID, impaired B cell differentiation and enhanced myelopoiesis are the key immunological features (Extended Data Table 1), which can be explained by the critical role of PLCγ2 in both cell types. This evidence concerns the gene PLCG2 and autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.